Showing results (1861-1870 of 1,997) with videos related to

Sort By:
Pageof 200
Plos One|October 11, 2012
qpure: A tool to estimate tumor cellularity from genome-wide single-nucleotide polymorphism profilesSarah Song, Katia Nones, David Miller, et al.
JAMA Network Open|May 15, 2024
Prioritization of Randomized Clinical Trial Questions for Children Hospitalized With Common Conditions: A Consensus StatementEric R Coon, Corrie E McDaniel, Natalia Paciorkowski, et al.
Annals of Surgery|February 6, 2023
The Impact of Molecular Subtyping on Pathological Staging of Pancreatic CancerStephan B Dreyer, Sarah Rae, Kirsty Bisset, et al.
The American Journal of Surgical Pathology|November 18, 2015
Fumarate Hydratase-deficient Uterine Leiomyomas Occur in Both the Syndromic and Sporadic SettingsWesley J Harrison, Juliana Andrici, Fiona Maclean, et al.
Clinical Genetics|June 17, 2026
The WHO Classification of Genetic Tumour Syndromes: Considerations for GeneticsIan A Cree, Mark J Arends, Joseph D Khoury, et al.
The Journal of Pathology|May 29, 2020
Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomasPaal W Wallace, Catleen Conrad, Sascha Brückmann, et al.
Histopathology|June 18, 2025
Assessment and classification of sex cord-stromal tumours of the testis: recommendations from the testicular sex cord-stromal tumour (TESST) group, an Expert Panel of the Genitourinary Pathology Society (GUPS) and International Society of Urological Pathology (ISUP)Andres M Acosta, Maurizio Colecchia, Eva Comperat, et al.
The Journal of Clinical Endocrinology and Metabolism|December 28, 2020
Multiple Endocrine Tumors Associated with Germline MAX Mutations: Multiple Endocrine Neoplasia Type 5?Amanda J Seabrook, Jessica E Harris, Sofia B Velosa, et al.
HIV Medicine|July 14, 2017
Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) studyS L Pett, J Amin, A Horban, et al.
Neuroendocrinology|August 3, 2021
International Validation of a Nomogram to Predict Recurrence after Resection of Grade 1 and 2 Nonfunctioning Pancreatic Neuroendocrine TumorsCharlotte M Heidsma, Stijn van Roessel, Susan van Dieren, et al.
Pageof 200